Aridol Disease Interactions
There are 2 disease interactions with Aridol (mannitol).
Osmotic diuretics (applies to Aridol) fluid overload
Major Potential Hazard, Moderate plausibility. Applicable conditions: Congestive Heart Failure, Pulmonary Edema, Anuria, Dehydration
The use of osmotic diuretics is contraindicated in patients with anuria, severe dehydration, pulmonary edema, or severe cardiac decompensation. An increase in the tonicity of the blood may occur in these patients that could exacerbate these conditions.
References
- "Product Information. Fleet Babylax (glycerin)." Alcon Laboratories Inc PROD (2001):
- "Product Information. Ismotic PB (isosorbide)." Alcon Laboratories Inc PROD (2001):
Osmotic diuretics (applies to Aridol) hyperosmolar effects
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease, Psychosis, Diabetes Mellitus, Renal Dysfunction
The use of osmotic diuretics is associated with an increase in blood tonicity. Osmotic diuretics should be administered cautiously in patients with confused mental states, diabetes, congestive heart failure, severe dehydration, and cardiac, renal, or hepatic disease.
References
- "Product Information. Fleet Babylax (glycerin)." Alcon Laboratories Inc PROD (2001):
- "Product Information. Ismotic PB (isosorbide)." Alcon Laboratories Inc PROD (2001):
Aridol drug interactions
There are 133 drug interactions with Aridol (mannitol).
More about Aridol (mannitol)
- Aridol consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous diuretics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.